Table 2.

Correlations Between Variables at Pretest-Spearman rho (2-sided p).

	CPZ-EQ	Blunted affect	Alogia	Avolition	Anhedonia	Expression	Experience
CDSS	0.05 (0.82)	0.14 (0.54)	0.00 (0.98)	0.13 (0.59)	0.21 (0.36)	0.09 (0.69)	0.20 (0.38)
CPZ-EQ		0.30 (0.19)	0.08 (0.75)	0.08 (0.74)	0.00 (0.98)	0.13 (0.58	0.06 (080)
Blunted affect			0.71 (0.00)	0.25 (0.27)	0.48 (0.03)	0.87 (< 0.01)	0.45 (0.04)
Alogia				0.05 (0.83)	0.16 (0.49)	0.95 (< 0.01)	0.20 (0.39)
Avolition					0.37 (0.10)	0.12 (0.61)	0.78 (< 0.01)
Anhedonia						0.30 (0.19)	0.83 (< 0.01)
Expression							0.29 (0.20)

CDSS, Calgary Depression Scale for Schizophrenia; CPZ-EQ, chlorpromazine equivalents; blunted affect, SANS withdrawal or emotional poverty; alogia, SANS alogia (lack of speech); avolition, SANS avolition and apathy (lack of energy and lack of initiative); anhedonia, SANS anhedonia and social withdrawal (loss of interests); experience, SANS composite score of the reduction of the capacity to experience; expression, SANS composite score of the reduction of expression.